The breast cancer message is familiar. For many men, recognizing themselves in it is not.

The American Cancer Society estimates about 2,670 U.S. men will be diagnosed with invasive breast cancer in 2026, and about 530 will die from it. Fewer than 1% of U.S. breast cancers occur in men; average lifetime risk is about 1 in 755, and the average age at diagnosis is between 60 and 70 — though it can occur at any age. (American Cancer Society)

Rare does not mean unimportant. And new research suggests the problem is not only awareness — it is access.

The new finding

On October 12, the American Cancer Society announced a study of 26,969 men diagnosed with stage 0–IV breast cancer from 2004 to 2023, drawn from the National Cancer Database. Men with private insurance were more likely to be diagnosed early, start treatment sooner, and live longer. Men without private insurance were less likely to be diagnosed early, more likely to face treatment delays, and had worse survival. (American Cancer Society press release, Oct. 12, 2026)

The most striking figure: the share of men who began treatment within 30 days of diagnosis dropped from 76% in 2004 to 36% in 2022. The researchers also reported differences by race and ethnicity, area-level poverty, and the type of facility providing care. (American Cancer Society)

"This is very concerning as our findings reveal health insurance is a key factor in access to critical cancer care for men with breast cancer," said Dr. Jingxuan Zhao, the study's senior author and an ACS principal scientist. She added that "the disease is often treated using recommendations that were developed primarily from breast cancer studies in women." (American Cancer Society)

Context readers need: the study is being presented at the ASCO Quality Care Symposium, October 16–17, as a conference abstract. It has not been described as a peer-reviewed journal article, and the release does not publish group-by-group figures. (American Cancer Society)

Who is most affected

According to Susan G. Komen, non-Hispanic Black men have the highest male breast cancer incidence rate — 2.1 per 100,000, compared with 1.4 for non-Hispanic white men — and a higher mortality rate than white and Hispanic men. Black men were also diagnosed younger, with a median age of 65 compared with 70 for white men (2018–2022 data). (Susan G. Komen)

Komen also notes that survival for men is about the same as for women at the same stage — but men are often diagnosed later. (Susan G. Komen) That makes stage at diagnosis, and the time between a symptom and a scan, the real story.

Stage matters enormously: five-year relative survival is 97% when the cancer is localized, compared with 31% when it has spread to distant organs. (National Breast Cancer Foundation, citing ACS)

The evidence gap behind the guidance

In 2020, the American Society of Clinical Oncology issued its first guideline on managing male breast cancer. It recommends genetic counseling and germline testing be offered to all men diagnosed with breast cancer, and tamoxifen as the preferred initial hormone therapy. (ASCO Guideline, Journal of Clinical Oncology, 2020) The guideline panel noted that more than 20% of male breast cancer patients may carry an identifiable inherited risk factor — which can matter for their daughters, sons, and siblings, too. (ASCO, JCO)

Risk factors named by ASCO include family history, Black race, chest radiation, inherited mutations such as BRCA2, and conditions linked to higher estrogen, such as Klinefelter syndrome. (ASCO, JCO)

One more less-discussed fact: there is no validated risk-prediction model for men, so men at elevated risk are often identified only after they or a female relative are diagnosed. (Journal of Breast Imaging)

What to watch for

A lump — often painless — near the nipple, nipple discharge or retraction, and skin changes deserve evaluation. "It doesn't hurt" is not a reason to wait. This article is not medical advice; talk with a clinician about any change.